Assistant Professor, Surgery, University of Michigan Medical School
General Surgery
Dr. Theodore H. Welling, MD
|
|
Give Review
Theodore H. Welling, MD is an expert in the field of General Surgery. He studied medicine at University of Michigan Medical School. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Theodore Welling is also a published doctor. He has 20 publication published. The most recent publication is: Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Theodore Welling accepts Medicare payments and is listed with Medicare.gov.
Publications
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.
- Internal Biliary stenting during orthotopic liver transplantation: anastomotic complications, post-transplant Biliary interventions, and survival.
- Alternative splicing of human NT5E in cirrhosis and hepatocellular Carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).
- Heterogeneity of The CD90(+) Population in Different Stages of Hepatocarcinogenesis.
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells.
- CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice.
- Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangioCarcinoma.
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment.
- Elevated serum IL-8 is associated with the presence of hepatocellular Carcinoma and independently predicts survival.
- c-Met is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target.
- Body mass index and adverse perioperative outcomes following hepatic resection.
- Influence of body mass index on complications and oncologic outcomes following hepatectomy for malignancy.
- Kupffer cell suppression of CD8+ T cells in human hepatocellular Carcinoma is mediated by B7-H1/programmed death-1 interactions.
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.
- FOXP3 defines regulatory T cells in human tumor and autoimmune Disease.
- InDuction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.
- Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following Liver transplantation.
- Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.
- Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors.
Schools
University Of Michigan Medical School
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- Biliary Drainage
- Cystectomy
- Decortication and Pleurectomy
- Embolectomy, Thrombectomy, or Vessel Exploration
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Bile Duct Cancer
- Biliary Atresia
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Health Alliance
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Paramount
- PHP-Physicians Health Plan
- Priority PPO
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1023109683 | |
| NPPES Provider LastName | WELLING | |
| NPPES Provider FirstName | THEODORE | |
| NPPES Provider ZIPCode | 481095332 | |
| NPPES Provider State | MI | |
| Specialty Description | General Surgery | |
| Total Claim Count | 88.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 12.5 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023109683 |
| Last Name Of The Provider | WELLING |
| First Name Of The Provider | THEODORE |
| View All |
Similar Doctors
|
|
Dr. Michael Englesbe, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paul S. Cederna, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rebecca M. Minter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Benjamin S. Bryner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eustace S. Golladay, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Alex C. Kim, MD |
|
|
Dr. Seth A. Waits, MD |
|
|
Dr. Peter T. White, MD |
|
|
Dr. Vahagn C. Nikolian, MD
This Doctor is OpenDoctor Recommended.
|